Amit Akirov, MD, Author at Endocrinology Advisor

Thyroid

Efficacy of Saliva Iodine Concentration as a Biomarker of Iodine Status in Children

By

Amit Akirov, MD

September 29, 2020

Saliva iodine concentration can serve as a good biomarker of recent iodine status in pediatric populations.

gray injection pen for medication with blue background

Diabetes

Once Weekly Semaglutide Reduced Mean HbA1c vs Empagliflozin

By

Amit Akirov, MD

September 25, 2020

Once weekly semaglutide provided superior glycemic control compared with empagliflozin when added to metformin monotherapy in uncontrolled T2D.

deformed woman's hands from rheumatoid arthritis

Bone Metabolism

Short-Term Romosozumab Highly Effective in RA and Primary Osteoporosis

By

Amit Akirov, MD

September 25, 2020

Researchers evaluated the short-term clinical efficacy of romosozumab in patients with rheumatoid arthritis and primary osteoporosis.

Bone Metabolism

Lung Disease-Specific Risk Factors for Hip Fracture in Smokers

By

Amit Akirov, MD

September 17, 2020

Several lung disease-related factors may help predict the risk for hip fracture in current and former smokers.

Thyroid

HDL Cholesterol Efflux May Be Impaired in Severe Short-Term Hypothyroidism

By

Amit Akirov, MD

September 15, 2020

High-density lipoprotein cholesterol efflux capacity may be impaired in patients with severe short-term hypothyroidism.

Diabetes

Therapeutic Levels of THC for Pain Reduction in Diabetic Neuropathy

By

Amit Akirov, MD

August 13, 2020

These results that there is a therapeutic window of THC concentrations for treatment of painful diabetic neuropathy.

General Endocrinology

Medication Misuse: Growth Hormone for Athletic Performance and Anti-Aging

By

Amit Akirov, MD

July 30, 2020

There has been a significant surge in the use of growth hormone to improve athletic ability and combat aging despite no clear supporting evidence.

Diabetes

Vitamin D Deficiency Linked to Painful Diabetic Neuropathy

By

Amit Akirov, MD

July 28, 2020

Vitamin D supplements may significantly improve neuropathic symptoms, including pain and quality of life.

Bone Metabolism

Patients With Neuromyelitis Optica at Increased Risk for Fracture

By

Amit Akirov, MD

July 27, 2020

Given the limited data is available on bone health of patients with NMOSD-AQP4, researchers aimed to investigate their risk for fracture and bone loss.

Diabetes

Effects of Exenatide With Pioglitazone or Insulin Therapy on Diabetic Neuropathy Measures

By

Amit Akirov, MD

July 24, 2020

Combined treatment with exenatide and pioglitazone or basal-bolus insulin may improve corneal confocal microscopy measures in diabetic neuropathy.

Amit Akirov, MD

All articles by Amit Akirov, MD

Efficacy of Saliva Iodine Concentration as a Biomarker of Iodine Status in Children

Once Weekly Semaglutide Reduced Mean HbA1c vs Empagliflozin

Short-Term Romosozumab Highly Effective in RA and Primary Osteoporosis

Lung Disease-Specific Risk Factors for Hip Fracture in Smokers

HDL Cholesterol Efflux May Be Impaired in Severe Short-Term Hypothyroidism

Therapeutic Levels of THC for Pain Reduction in Diabetic Neuropathy

Medication Misuse: Growth Hormone for Athletic Performance and Anti-Aging

Vitamin D Deficiency Linked to Painful Diabetic Neuropathy

Patients With Neuromyelitis Optica at Increased Risk for Fracture

Effects of Exenatide With Pioglitazone or Insulin Therapy on Diabetic Neuropathy Measures

Higher Vitamin C, Carotenoid Intake May Lower Risk for T2D